GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cardax CDXI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2020

Revenue

$538,946

FY2014FY2020

Net income

−$5.1m

FY2014FY2020

Free cash flow

−$1.8m

FY2014FY2020

Shareholders' equity

−$10.2m

FY2014FY2020

Income statement

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$538,946$710,949$1.5m$610,323$35,258——
Research and development$136,780$315,994$269,077$460,991$347,885$491,829$1.2m
Operating income−$3.1m−$4.1m−$4.0m−$2.0m−$1.8m−$4.4m−$16.9m
Net income−$5.1m−$5.1m−$4.0m−$2.0m−$1.8m−$4.3m−$17.0m
Diluted earnings per share-6.37-7.42-6.02-0.02-0.02-0.06-0.27

Balance sheet

At each fiscal year end

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$1.4m$2.0m$2.5m$3.2m$750,580$852,078$1.5m
Cash and short-term investments$19,179$19,303$243,753$2.2m$158,433$323,410$35,696
Total liabilities$11.6m$9.2m$6.0m$4.6m$4.6m$4.6m$4.8m
Debt$4.8m$2.6m—————
Shareholders' equity−$10.2m−$7.2m−$3.5m−$1.4m−$3.9m−$3.7m−$3.2m
Shares outstanding1m1m1m122m83m69m64m

Cash flow

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$1.8m−$3.5m−$3.2m−$2.1m−$1.3m−$1.5m−$5.7m
Capital spending−$14,613−$61,613−$36,593−$19,408−$29,206−$22,049−$28,303
Free cash flow−$1.8m−$3.6m−$3.2m−$2.1m−$1.3m−$1.5m−$5.7m

Latest quarters

By quarter end

Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020Dec 2019Sept 2019Jun 2019
Revenue$104,574$195,110$66,502$134,521$142,813$271,444$229,142$45,391
Operating income−$771,312−$661,813−$705,760−$789,032−$906,031−$721,717−$1.2m−$1.0m
Net income−$1.8m−$997,966−$1.8m−$2.7m−$1.5m−$1.4m−$1.4m−$1.1m
Diluted earnings per share-2.29-1.26-2.23-3.42-1.83-2.10-2.09-1.58
Total assets$1.4m$1.4m$1.8m$1.7m$1.9m$2.0m$2.1m$2.1m
Cash and short-term investments$58,650$19,179$107,185$30,349$51,191$19,303$7,470$31,451
Debt$5.4m$2.7m$3.3m$2.9m$2.9m$2.6m$2.4m$1.6m
Shareholders' equity−$11.4m−$10.2m−$9.6m−$8.6m−$7.6m−$7.2m−$6.3m−$5.1m

Valuation history

At each fiscal year end

FY2019FY2018FY2017FY2016FY2015
Price to earnings——-0.8-0.2-0.0
Price to sales0.00.02.59.0—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%450%-100%669%-85%-59%31%263%354%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 200-to-1 reverse split · 15 Jan 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.